What you should know:
1. Exact expects to have the ability to process 7 million Cologuard tests by the end of 2019. Cologuard is a noninvasive screening test for colorectal cancer.
2. The newly opened lab can process 4 million tests, while Exact’s existing lab can process 3 million tests. Exact has processed more than 2 million Cologuard tests since 2014, when the test earned FDA approval.
3. The lab is on a property Exact labeled the Discovery Campus. Exact moved its customer care team into a neighboring office building and will open a large parking structure soon. A production and manufacturing space also sits on the campus.
More articles on surgery centers:
American Pain Society considers bankruptcy — 4 details
NAPA anesthesiologists win national performance accolade — 4 details
Viewpoint: How payers are suppressing anesthesia payments — 3 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
